Carbamoyl-DL-Ala-OH

Carbamoyl-DL-Ala-OH is a carbamoylated alanine derivative bearing a free carboxylic acid and a carbamoyl-modified amino functionality, with a DL stereochemical designation indicating racemic composition at the alanine stereocenter. The molecule combines an amide-like carbamoyl group with a carboxylic acid, giving it a defined hydrogen-bonding and polarity profile that supports controlled reactivity during amino acid derivatization and peptide-related transformations. The carbamoyl substituent can participate in acyl-transfer and coupling workflows after appropriate activation, while the free acid enables downstream esterification, salt formation, or conversion to peptide-compatible activated derivatives. As a chiral-agnostic alanine-based intermediate, Carbamoyl-DL-Ala-OH can be used to prepare racemic alanine analogs, to tune protecting-group patterns, or to generate defined amino acid fragments for synthetic and analytical studies.

1. Peptide Coupling Chemistry

Carbamoyl-DL-Ala-OH supports peptide coupling chemistry as an alanine-based amino acid derivative in which the carbamoyl functionality provides an amide-linked nitrogen handle and the free carboxylic acid enables activation to peptide-grade intermediates. The presence of a stable carbamoyl moiety can be leveraged to manage chemoselectivity during sequential synthesis, particularly when building peptide fragments or preparing alanine-containing sequences under conditions compatible with carbamoyl-stabilized nitrogen. Racemic stereochemistry allows incorporation into non-stereochemically constrained peptide analogs, diastereomer-agnostic libraries, or mechanistic studies where stereochemical purity is not required. Downstream formation of amide bonds through carboxyl activation enables conversion into peptide building blocks and supports fragment assembly for broader amino acid chemistry workflows.

2. Amino Acid Derivatization

Carbamoyl-DL-Ala-OH functions as a derivatizable alanine intermediate for generating substituted amino acid derivatives used in synthetic organic chemistry and biochemical reagent preparation. The free carboxylic acid can be transformed into esters, acid chlorides, mixed anhydrides, or coupling-ready activated species, while the carbamoyl group can undergo targeted deprotection or further functional group interconversions depending on the chosen chemistry. DL stereochemistry supports preparation of racemic standards, method-development substrates, and calibration materials where enantiomer separation is not the primary objective. The resulting derivatives can be used to probe structure-function relationships, to create labeled or tagged analogs, or to feed downstream syntheses of protected and functionalized alanine derivatives.

3. Analytical Reference Standards

Carbamoyl-DL-Ala-OH is suitable for analytical research as a defined amino acid derivative containing both a carbamoyl-modified nitrogen and a free acid, enabling reproducible chromatographic and spectroscopic behavior. The racemic composition provides a consistent reference material for method validation in amino acid derivatization assays, LC-MS/MS quantitation workflows, and impurity profiling of carbamoylated alanine species. The functional group pattern supports detection strategies that differentiate carbamoyl-containing analytes from unmodified alanine by exploiting characteristic fragmentation and ionization responses. Downstream utility includes use as a calibration component or internal reference for synthetic monitoring, quality control studies, and analytical method development in peptide-related and amino acid derivative manufacturing contexts.

4. Pharmaceutical Intermediate Preparation

Carbamoyl-DL-Ala-OH can be applied in pharmaceutical intermediate preparation where alanine-derived fragments are converted into building blocks for peptidomimetic scaffolds and controlled nitrogen-containing intermediates. The combination of a carbamoyl-protected/functionalized amino group and a free carboxylic acid supports integration into multi-step synthetic routes that require predictable chemoselectivity during coupling, protection pattern adjustment, and side-chain or backbone functionalization. Racemic stereochemistry can be advantageous for early-stage synthetic exploration, library generation, or route scouting when enantiopure material is not yet mandated. Conversion into activated carboxyl derivatives enables incorporation into larger intermediates used for downstream synthesis of peptide-like structures and nitrogen-functionalized fine chemicals.

5. Process Chemistry Intermediate

Carbamoyl-DL-Ala-OH is suitable for process chemistry intermediate preparation due to its well-defined functional groups that align with scalable amino acid handling operations such as activation of the carboxylic acid and controlled nitrogen chemistry around the carbamoyl moiety. The free acid allows straightforward conversion into salts or activated derivatives, while the carbamoyl group can help regulate reactivity during sequential transformations in a manufacturing route. DL stereochemistry can reduce complexity in early process development by avoiding enantioselective steps when racemic substrates are acceptable for intermediate generation or for producing stereochemically mixed libraries. Downstream, the compound can serve as a feedstock for producing carbamoylated alanine derivatives, peptide-coupling intermediates, and related amino acid-based materials used in industrial chemical manufacturing and fine chemical synthesis.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis